Shawn Cross, Chief Financial Officer at Pacira BioSciences, Inc. (PCRX), sold 50,000 shares at $25.14 ($1.3M) on 2025-12-10, disclosed to the SEC on 2025-12-11.
Scheduled sale ($1.3M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.03 | 15,896 | $398K | 31.7% |
| 2 | $25.03 | 15,896 | $398K | 31.7% |
| 3 | $25.14 | 9,104 | $229K | 18.3% |
| 4 | $25.14 | 9,104 | $229K | 18.3% |
| Total | $25.07 avg | 50,000 | $1.3M | 100% |
| Filing → |
| PCRX | SELL | 2025-11-13 | $533K | — | Filing → |
| AMTI | SELL | 2023-11-24 | $18K | — | Filing → |
| AMTI | SELL | 2023-11-16 | $14K | — | Filing → |